11 December 2025

SOLASTA Bio accelerates path to market with new patents and Asia trial success

SOLASTA Bio now possesses 14 granted patents for our proprietary peptides, including eight in the United States and six in Europe. Building on over 50 greenhouse and field trials, SOLASTA® Bio has broadened its testing program to include critical global staple crops such as rice, alongside ongoing evaluations on high-value leafy greens and soft fruit crops. This expanded trial footprint demonstrates the versatility and adaptability of our peptide-based platform across varied agricultural environments and geographies.